Storys zum Thema Finances

Folgen
Keine Story zum Thema Finances mehr verpassen.
Filtern
  • 10.11.2009 – 09:16

    SYGNIS AG

    EANS-News: Sygnis Pharma AG reports on second quarter 2009/2010

    Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Accounting and Audits/Company Information/Financial Figures/Balance Sheet/quarterly report/6-month report Heidelberg (euro adhoc) - Heidelberg, November 10, 2009 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today ...

  • 10.11.2009 – 08:31

    Epigenomics AG

    EANS-News: Epigenomics AG Reports Q3 and Nine Months 2009 Results

    Key Figures 9M 2009 Revenue, EBIT and net loss significantly improved * Revenue: EUR 3.2 million in 9M 2009, up by 77% (9M 2008: EUR 1.8 million) * EBIT: EUR - 7.1 million in 9M 2009, improved by 17% (9M 2008: EUR -8.5 million) * Net loss: EUR - 7.1 million in 9M 2009, decreased by 13% (9M 2008: EUR -8.1 million) * Liquid assets: EUR 9.5 million at end of September 2009 (31/12/2008: EUR 12.1 million) ...

  • 10.11.2009 – 08:06

    A-TEC Industries AG

    EANS-Adhoc: A-TEC Industries AG / Financial report Q1-Q3 2009

    ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 9-month report 10.11.2009 Highlights: - Order backlog down again at EUR 2.4 billion (bn) as of 30 September 2009 (30 June 2009: EUR 2.7bn), due to low order intake, particularly in the Plant Construction Division (the comparative period was marked by an ...

  • 10.11.2009 – 08:01

    Vienna Insurance Group

    EANS-Adhoc: Vienna Insurance Group in the 1st to 3rd quarter 2009

    ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Results 9M 2009 10.11.2009 - Group premiums of more than EUR 6 billion - Solid development of the result - profit (before taxes, consolidated) about EUR 340 million - Continuing growth in the CEE core markets* - Excellent capitalisation of the ...